AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The HemOnc Pulse
Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
Mar 14, 2024
Discussing the role of measurable residual disease in ALL treatment, advancements in TKIs for Ph+ ALL, medication-based treatments for high-risk patients, innovative strategies for Ph- leukemia patients, and the importance of achieving MRD negativity in leukemia therapy.
19:47
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Tyrosine kinase inhibitors have significantly improved survival outcomes in Ph+ ALL, reducing the need for transplantation.
- Integrating immunotherapy upfront in Philadelphia negative ALL has led to universal response rates and MRD negativity in 80% of cases, enhancing survival rates.
Deep dives
Treatment Advances for Philadelphia Positive Acute Lymphoblastic Leukemia
In the podcast, Dr. Elijah Bohr from MD Anderson Cancer Center discusses treatment strategies for Philadelphia positive acute lymphoblastic leukemia (ALL). Historically, patients with this type of ALL had poor outcomes, with survival rates of only 10%. The introduction of tyrosine kinase inhibitors improved outcomes significantly to 40-60%, addressing the issue of relapses due to resistance. The combination of chemotherapy and potent new drugs like ponatinib has led to survival rates of 75%, eliminating the need for transplantation in some cases.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode